The Structural Disease Center

Filter Your Results

 

News

 

United States Feasibility Study Begins for Conformal LAA Seal for Stroke Prevention

April 9, 2019 -- Conformal Medical, Inc. announced the first human use of its left atrial appendage (LAA) occlusion technology for the prevention of stroke in patients with at…

SCAI Publishes Recommendations for Use of PFO Closure Technologies

April 1, 2019 -- The Society for Cardiovascular Angiography and Interventions (SCAI) announced the publication of an expert consensus statement that provides recommendations f…

FEops Heartguide Platform Receives CE Mark Approval for Planning Structural Heart Interventions

April 1, 2019 -- FEops announced CE Mark approval for the Heartguide procedural planning environment for structural heart interventions. The technology provides physicians wit…

Boston Scientific's Watchman FLX Left Atrial Appendage Closure Device Approved in Europe

March 13, 2019 -- Boston Scientific Corporation announced it has received European CE Mark approval of the next-generation Watchman FLX left atrial appendage closure (LAAC) de…

Micro Interventional Devices, Inc. Enters Strategic Alliance With Oscor, Inc.

March 11, 2019 -- Micro Interventional Devices, Inc. (MID) and Oscor, Inc. announced a strategic alliance to develop and commercialize solutions to structural heart disease, s…

Edwards Lifesciences Announces Strategic Investments

March 11, 2019 -- Edwards Lifesciences Corporation announced strategic transactions involving companies with structural heart disease technologies: Corvia Medical, Inc. and Mi…

The Next Wave of Mechanical Circulatory Support Devices

Carlo R. Bartoli, MD, PhD; and Robert D. Dowling, MD, PhD (Hon)

January/February 2019—Next-generation mechanical circulatory support devices in different phases of development and clinical use are anticipated to improve outcomes and quality of life in patients with advanced heart failure.

Edwards' Pascal Transcatheter System Receives CE Mark Approval

February 19, 2019 -- Edwards Lifesciences announced that its Pascal transcatheter valve repair system has received European CE Mark approval for the treatment of patients with…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.